Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Lewis

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Acta Diabetologica|May 18, 2013
CD2AP is associated with end-stage renal disease in patients with type 1 diabetesMervi E Hyvönen, Pekka Ihalmo, Niina Sandholm, et al.
Clinical Pharmacology and Therapeutics|October 18, 2024
Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry PerspectiveMicaela B Reddy, Tamara D Cabalu, Loeckie de Zwart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2021
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal DrugsElizabeth O'Shaughnessy, Yuliya Yasinskaya, Cheryl Dixon, et al.
G3 (Bethesda, Md.)|June 6, 2023
Generation of LexA enhancer-trap lines in Drosophila by an international scholastic networkElla S Kim, Arjun Rajan, Kathleen Chang, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Acta Diabetologica|May 18, 2013
CD2AP is associated with end-stage renal disease in patients with type 1 diabetesMervi E Hyvönen, Pekka Ihalmo, Niina Sandholm, et al.
Clinical Pharmacology and Therapeutics|October 18, 2024
Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry PerspectiveMicaela B Reddy, Tamara D Cabalu, Loeckie de Zwart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2021
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal DrugsElizabeth O'Shaughnessy, Yuliya Yasinskaya, Cheryl Dixon, et al.
G3 (Bethesda, Md.)|June 6, 2023
Generation of LexA enhancer-trap lines in Drosophila by an international scholastic networkElla S Kim, Arjun Rajan, Kathleen Chang, et al.
Pageof 4